The development and commercialisation pact between Novavax and SII excludes major upper-middle and high-income countries as they retain the rights
The company is aiming to launch the vaccine being produced in collaboration with American vaccine development company Novavax by June 2021, SII CEO Adar Poonawalla said
Delhi's COVID cases continue to spike, SII completes phase-3 enrollment; country's tally at 86.83 lakh
The health ministry highlighted that 78 percent of the new cases were from 10 states and Union Territories (UTs) with Delhi continuing to register the highest single-day infections
Phase 3 of the COVISHIELD human trials will involve 1600 participants.